Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma

详细信息    查看全文

• 作者：Koseki Kimura^a ; Tsunao Kishida^b ; Junko Wakao^a ; Tomoko Tanaka^a ; Mayumi Higashi^a ; Shigehisa Fumino^a ; Shigeyoshi Aoi^a ; Taizo Furukawa^a ; Osam Mazda^b ; Tatsuro Tajiri^a ; ^{taji@koto.kpu-m.ac.jp}
• 关键词：Neuroblastoma ; Mesenchymal stem cell ; Homing ; TH-MYCN transgenic mouse ; IVIS
• 刊名：Journal of Pediatric Surgery
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：51
• 期：12
• 页码：2068-2073
• 全文大小：1044 K
• 卷排序：51

文摘

Human mesenchymal stem cells (hMSCs) are multipotent stem-like cells that are reported to have tumor-suppression effects and migration ability toward damaged tissues or tumors. The aim of this study was to analyze the tumor-homing ability of hMSCs and antitumor potency in a transgenic TH-MYCN mouse model of neuroblastoma (NB).MethodshMSCs (3 × 106) labeled with DiR, a lipophilic near-infrared dye, were intraperitoneally (i.p.) or intravenously (i.v.) administered to the TH-MYCN mice. hMSC in vivo kinetics were assayed using the IVIS® imaging system for 24 h after injection. Immunohistochemistry using human CD90 antibody was also performed to confirm the location of hMSCs in various organs and tumors. Furthermore, the survival curve of TH-MYCN mice treated with hMSCs was compared to a control group administered PBS.Resultsi.p. hMSCs were recognized in the tumors of TH-MYCN mice by IVIS. hMSCs were also located inside the tumor tissue. Conversely, most of the i.v. hMSCs were captured by the lungs, and migration into the tumors was not noted. There was no significant difference in the survival between the hMSC and control groups.ConclusionThe present study suggested that hMSCs may be potential tumor-specific therapeutic delivery vehicles in NB according to their homing potential to tumors.